Quantcast
Last updated on April 18, 2014 at 7:49 EDT

Latest Prostate cancer Stories

2013-11-19 08:29:08

SAN DIEGO, Nov. 19, 2013 /PRNewswire/ -- Cardium Therapeutics (NYSE MKT: CXM) today presented its financial results for the third quarter ended September 30, 2013, and reported on recent highlights and other business developments including: -- Sale of To Go Brands® business to Cell-nique Corporation and Healthy Brands Collective® in an asset purchase for approximately $2.5 million through the exchange of a preferred equity position in Healthy Brands. Healthy...

2013-11-19 08:27:41

--Study Will Test Feasibility of Using Crowdsourcing for Protocol Design and Telemonitoring to Collect Patient Data in Cancer Trials-- NEW YORK, Nov. 19, 2013 /PRNewswire/ -- Transparency Life Sciences, LLC (TLS), the world's first drug development company based on open innovation, today announced that it is collaborating with Dr. Matthew Galsky, Associate Professor of Medicine, Division of Hematology/Oncology at the Icahn School of Medicine at Mount Sinai, to design and conduct...

2013-11-19 08:27:15

SYNERGY Trial to Continue as Planned Following Completion of Interim Efficacy Analysis BOTHELL, Wash. and VANCOUVER, British Columbia, Nov. 19, 2013 /PRNewswire/ -- OncoGenex Pharmaceuticals, Inc. (NASDAQ: OGXI) today announced that the SYNERGY trial is continuing as planned per the recommendation of the Independent Data Monitoring Committee (IDMC). The primary registration Phase 3 SYNERGY trial is designed to evaluate a survival benefit for custirsen in combination with first-line...

2013-11-18 23:03:35

Screening program offers access to highly specialized thoracic radiologists to improve early detection and provides multi-disciplinary approach to treatment. Kansas City, MO (PRWEB) November 18, 2013 Lung cancer is the most commonly diagnosed cancer in the United States and claims more lives than breast, colon, and prostate cancers combined. Early detection dramatically improves treatment outcomes but often early stages of lung cancer go undetected thus increasing the need for...

2013-11-18 23:02:26

The Organic and Environmental Products website has many research articles and other eBooks on many different subjects to help customers know all there is about any health problems they may have. Lake View Terrace, CA (PRWEB) November 18, 2013 Organic and Environmental Products have recently written and released five new eBooks that can be read and download for no cost at all. These five new eBooks contain a ton of information on these topics: 1. Scurvy 2. Foods That Affect Health and...

2013-11-18 20:54:12

DNA regulator stops cancer cells in their tracks Understanding how and why cancer cells move away from their original location is important to find ways to stop the spread of the disease. New findings, published in the Nature journal Oncogene, reveal how a protein, called 'PRH', is normally able to prevent cells from unnecessary migration. It is likely that this protein is less effective in cancer cells allowing the cells to venture away. Researchers from the Universities of Bristol and...

2013-11-15 23:19:26

During National Lung Cancer Awareness Month, Allsup cites lung cancer as third leading cancer diagnosis for Social Security Disability Insurance claims. Belleville, IL (PRWEB) November 15, 2013 This year, an estimated 228,000 new cases of lung cancer will be diagnosed and nearly 160,000 people will die from the disease, according to the National Cancer Institute. New research about treating lung cancer points to the importance of individuals understanding their options through the Social...

2013-11-15 11:06:52

Treatment of pelvic nodes individualized by inclusion of sentinel nodes (SN) can be easily integrated into an IMRT-based treatment strategy, according to the new study conducted by a group of researchers from Tübingen and Munich in Germany. The target volume concept seems to correctly cover individual pelvic nodes, which is indicated by the absence of any nodal recurrence within five years of follow-up. The results of the study are to be presented at the 5th European Multidisciplinary...

2013-11-15 04:21:18

WHIPPANY, N.J., Nov. 15, 2013 /PRNewswire/ -- Bayer HealthCare announced today that the European Commission has granted marketing authorization for Xofigo(®) (radium Ra 223 dichloride) solution for injection for the treatment of adults with castration-resistant prostate cancer (CRPC), symptomatic bone metastases and no known visceral metastases. This decision follows a positive recommendation from the European Committee for Medicinal Products for Human Use (CHMP) in September of...

2013-11-13 08:26:15

Journal of Clinical Oncology Publishes Positive Results from Third Successful Validation in Stage II Colon Cancer, First Validation in Patients with Stage III Disease REDWOOD CITY, Calif., Nov. 13, 2013 /PRNewswire/ -- Genomic Health, Inc. (Nasdaq: GHDX) today announced that the Journal of Clinical Oncology (JCO) has published positive results from a large, independent validation study of the Oncotype DX(®) colon cancer test in patients from the National Surgical Adjuvant Breast and...